Drugs / [^13C4D3^15N]-baricitinib
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02340104 | Jan → Feb 2015 | — | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [^13C4D3^15N]-baricitinib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02340104 ↗ |
| Route | Intravenous | “administered intravenously (IV)” NCT02340104 ↗ |